Analyst Consensus ?
ConsensusBuy12 ratings
Bullish12100.0%
Neutral00.0%
Bearish00.0%
FN2 Earnings Intelligence
American Healthcare REIT, Inc. analyst ratings
American Healthcare REIT, Inc. (AHR) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$52.3Current
$28Low
$55.88Average
$70High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Sep 22, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Scotiabank | Sector Outperform | Sector Outperform | Maintain | Sep 2, 2026 |
| Barclays | Overweight | Overweight | Maintain | Aug 31, 2026 |
| Keybanc | Overweight | Overweight | Maintain | Aug 19, 2026 |
| Truist Securities | Buy | Buy | Maintain | Aug 14, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Aug 14, 2026 |
| Citigroup | Buy | Buy | Maintain | Aug 13, 2026 |
| Citizens | Market Outperform | Market Outperform | Maintain | Jul 27, 2026 |
| UBS | Buy | Buy | Maintain | Jul 8, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Nov 20, 2025 |
| JMP Securities | Market Outperform | Market Outperform | Maintain | Oct 17, 2025 |
| Citizens Capital Markets | Market Outperform | Market Outperform | Maintain | Mar 4, 2025 |
| B of A Securities | Buy | Buy | Maintain | Sep 24, 2024 |
Named analyst price targets
Upside is calculated against the persisted current price $52.3. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| UBS | Analyst unavailable | $65 | $54.22 | +24.3% | Sep 14, 2026 |
| Scotiabank | Nicholas Yulico | $62 | $55.83 | +18.5% | Sep 2, 2026 |
| Barclays | Richard Hightower | $66 | $55.53 | +26.2% | Aug 31, 2026 |
| KeyBanc | Analyst unavailable | $68 | $54.42 | +30.0% | Aug 19, 2026 |
| Truist Financial | Analyst unavailable | $61 | $54.14 | +16.6% | Aug 14, 2026 |
| RBC Capital | Analyst unavailable | $61 | $54.09 | +16.6% | Aug 14, 2026 |
| Compass Point | Rob Simone | $70 | $56.66 | +33.8% | Jul 21, 2026 |
| UBS | Analyst unavailable | $63 | $54.78 | +20.5% | Jul 8, 2026 |
| Barclays | Richard Hightower | $61 | $53.83 | +16.6% | Jul 7, 2026 |
| KeyBanc | Analyst unavailable | $58 | $50.46 | +10.9% | May 28, 2026 |
| RBC Capital | Michael Carroll | $56 | $50.66 | +7.1% | May 26, 2026 |
| Truist Financial | Michael Lewis | $57 | $52.13 | +9.0% | Mar 12, 2026 |
| Goldman Sachs | Analyst unavailable | $60 | $52.24 | +14.7% | Mar 2, 2026 |
| BMO Capital | Juan Sanabria | $55 | $46.33 | +5.2% | Jan 29, 2026 |
| Truist Financial | Michael Lewis | $52 | $48.01 | -0.6% | Jan 20, 2026 |
| Truist Financial | Analyst unavailable | $53 | $49.51 | +1.3% | Nov 26, 2025 |
| Morgan Stanley | Analyst unavailable | $55 | $49.56 | +5.2% | Nov 20, 2025 |
| Morgan Stanley | Ronald Kamdem | $52 | $47.87 | -0.6% | Nov 17, 2025 |
| JMP Securities | Analyst unavailable | $50 | $42.47 | -4.4% | Oct 17, 2025 |
| KeyBanc | Analyst unavailable | $43 | $41.29 | -17.8% | Oct 14, 2025 |
| UBS | Analyst unavailable | $51 | $42.49 | -2.5% | Sep 19, 2025 |
| Scotiabank | Analyst unavailable | $47 | $42.66 | -10.1% | Aug 28, 2025 |
| Truist Financial | Michael Lewis | $46 | $42.5 | -12.0% | Aug 26, 2025 |
| RBC Capital | Michael Carroll | $45 | $40.46 | -14.0% | Aug 13, 2025 |
| Jefferies | Joe Dickstein | $37 | $31.11 | -29.3% | Apr 28, 2025 |
| JMP Securities | Analyst unavailable | $35 | $30.54 | -33.1% | Mar 4, 2025 |
| Truist Financial | Michael Lewis | $29 | $26.51 | -44.6% | Nov 15, 2024 |
| Truist Financial | Michael Lewis | $27 | $25.85 | -48.4% | Sep 20, 2024 |
| KeyBanc | Austin Wurschmidt | $28 | $25.66 | -46.5% | Sep 20, 2024 |
| KeyBanc | Austin Wurschmidt | $27 | $24.58 | -48.4% | Sep 16, 2024 |
| Truist Financial | Michael Lewis | $22 | $20.93 | -57.9% | Sep 3, 2024 |
| Truist Financial | Michael Lewis | $17 | $14.61 | -67.5% | Jun 28, 2024 |
| Truist Financial | Michael Lewis | $16 | $14.1 | -69.4% | Apr 3, 2024 |
Track every rating change on AHR the moment it posts. Free to start.
Start freeGet the AHR recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.